Icariin Acts as a Potential Agent for Preventing Cardiac Ischemia/Reperfusion Injury
Authors:
- 8 February 2015
- journal article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 72 (2) , 589-597
Abstract
Myocardial infarction is a leading cause of mortality and morbidity worldwide. Although essential for successful recovery, myocardium reperfusion is associated with reperfusion injury. Icariin, a major flavonoid of Epimedium koreanum Nakai, has been proven to exert efficacy for improving cardiovascular function. We investigated the molecular effect and signal pathway of icariin on cardiac ischemia/reperfusion injury. In an in vivo model of infarct in rats, icariin (10 mg/kg) significantly attenuated myocardial infarct size induced by ischemia/reperfusion (I/R). From the TUNEL assay, icariin reduced the apoptotic cell induced by I/R and decreased blood indicators of creatine kinase, ischemia-modified albumin, and lactate dehydrogenase. All this effect was antagonized by the PI3K inhibitor LY294002. Meanwhile, icariin activated the PI3K/Akt/eNOS pathway. The PI3K inhibitor LY294002 suppressed icariin-mediated protective effect. These results suggest that icariin protects against myocardial ischemia reperfusion injury in rats by activating the PI3K/Akt/eNOS-dependent signal pathways and may be a useful drug for angiogenic therapy.Keywords
This publication has 28 references indexed in Scilit:
- Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heartJournal of Advanced Pharmaceutical Technology & Research, 2012
- Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathwayCancer Letters, 2010
- Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibitionLife Sciences, 2008
- Icariin: A Special Antioxidant To Protect Linoleic Acid against Free-Radical-Induced Peroxidation in MicellesThe Journal of Physical Chemistry A, 2006
- The antioxidative effect of icariin in human erythrocytes against free-radical-induced haemolysisJournal of Pharmacy and Pharmacology, 2004
- Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase-Akt PathwayCirculation Research, 2004
- A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemiaTransfusion and Apheresis Science, 2004
- Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial IschemiaCirculation, 2001
- A fresh look at reperfusion injuryCardiovascular Research, 1998
- Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyThe Lancet, 1997